Business
Statement re: Silicon Valley Bank (SVB)
Statement re: Silicon Valley Bank (SVB).
About this update from Scancell Holdings Plc
[{"type":"text","content":"\n \n \n 13 March 2023\n \n \n \n \n \n \n Scancell Holdings plc\n \n \n \n (\"Scancell\" or the \"Company\")\n \n \n \n \n \n \n \n \n Statement re: Silicon Valley Bank (SVB)\n \n \n \n \n \n \n \n \n Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, can confirm that it has no banking relationship with either Silicon Valley Bank (\"SVB\") or Silicon Valley Bank UK (\"SVB UK\") and therefore no cash on deposit with them.\n \n \n \n \n \n This announcement follows the closure of SVB by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (\"FDIC\") as receiver, and the statement by the Bank of England noting that it has placed SVB UK into resolution.\n \n \n \n \n \n This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR).\n \n \n \n \n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Scancell Holdings plc\n \n \n \n \n \n +44 (0) 20 3727 1000\n \n \n \n \n \n \n Dr Jean-Michel Cosséry, Non-Executive Chairman\n \n \n \n \n \n \n \n \n \n \n \n \n \n Professor Lindy Durrant, CEO\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel Nicolaus Europe Limited\n \n (Nominated Adviser and Joint Broker)\n \n \n \n \n +44 (0) 20 7710 7600\n \n \n \n \n \n \n Nicholas Moore/\n Samira Essebiyea/William Palmer-Brown\n (Healthcare Investment Banking)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Nick Adams/Nick Harland (Corporate Broking)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Panmure Gordon (UK) Limited\n \n (Joint Broker)\n \n \n \n \n +44 (0) 20 7886 2500\n \n \n \n \n \n \n Freddy Crossley/Emma Earl (Corporate Finance)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Rupert Dearden (Corporate Broking)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n FTI Consulting\n \n \n \n \n \n +44 (0) 20 3727 1000\n \n \n \n \n \n \n Simon Conway/Rob Winder/Alex Davis\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Scancell\n \n \n \n \n \n \n \n \n Scancell is ...